538
Articles
26K
Citations
10
avg. Impact Factor
80
h-index

Most Cited Articles of Center for Virology and Vaccine Research in 2022

TitleJournalYearCitations
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.JAMA - Journal of the American Medical Association202216
Advances and gaps in SARS-CoV-2 infection models.PLoS Pathogens202213
Reduced Pathogenicity of the SARS-CoV-2 Omicron Variant in Hamsters.Med202213
Characterization of immune responses in fully vaccinated individuals following breakthrough infection with the SARS-CoV-2 delta variant.Science Translational Medicine202212
mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions.Science Translational Medicine202211
Structural and functional impact by SARS-CoV-2 Omicron spike mutations.Cell Reports20228
Defining the risk of SARS-CoV-2 variants on immune protection.Nature20227
Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.Lancet, The20227
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged miceScience Translational Medicine20226
SARS-CoV-2 receptor binding domain displayed on HBsAg virus-like particles elicits protective immunity in macaques.Science Advances20223
COVID-19 Vaccines and SARS-CoV-2 Transmission in the Era of New Variants: A Review and Perspective.Open Forum Infectious Diseases20223
Vaccine protection against the SARS-CoV-2 Omicron variant in macaques.Cell20223
Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of mice.Npj Vaccines20222
Serological Markers of SARS-CoV-2 Reinfection.MBio20221
A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques.Med20221
A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2-specific immune responses in rhesus macaques.Science Translational Medicine20221
Passive transfer of Ad26.COV2.S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamsters.Npj Vaccines20220
Ad26.COV2.S prevents upregulation of SARS-CoV-2 induced pathways of inflammation and thrombosis in hamsters and rhesus macaques.PLoS Pathogens20220
Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates.PLoS Biology20220
Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques.Npj Vaccines20220